Ubp Investment Advisors Sa Abb Vie Inc. Transaction History

Ubp Investment Advisors Sa

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $344,050 - $437,400	-2,500 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$102.3 - $112.62 $214,420 - $236,051	-2,096 Reduced 45.6%	2,500 $270,000
Q4 2020 Feb 23, 2021	SELL	$80.49 - $108.67 $82,985 - $112,038	-1,031 Reduced 18.32%	4,596 $492,000
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $89,987 - $121,493	1,118 Added 24.79%	5,627 $603,000
Q3 2020 Oct 22, 2020	BUY	$85.91 - $100.83 $2,577 - $3,024	30 Added 0.67%	4,509 $395,000
Q2 2020 Aug 05, 2020	BUY	$73.37 - $98.18 $73,370 - $98,180	1,000 Added 28.74%	4,479 $440,000
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $224,395 - $340,211	3,479 New	3,479 $265,000
Q4 2019 Jan 27, 2020	SELL	$72.13 - $90.25 $193,669 - $242,321	-2,685 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $169,101 - $203,308	2,685 New	2,685 $203,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Ubp Investment Advisors Sa, based on Form 13F filings with the SEC.

Stay updated on Ubp Investment Advisors Sa with notifications on news.